Tech Company Financing Transactions
MicroBiome Therapeutics Funding Round
Lagniappe Angels, NO/LA Angel Network and private investors participated in a $1 million Series B funding round for MicroBiome Therapeutics. The round closed on 11/3/2017.
Transaction Overview
Company Name
Announced On
11/3/2017
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to launch its clinically-tested microbiome modulator product in 2018.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5500 Prytania St. 530
New Orleans, LA 70115
USA
New Orleans, LA 70115
USA
Phone
Website
Email Address
Not Recorded
Overview
MicroBiome Therapeutics is developing medical food and pharmaceutical products that improve health status by interacting with the human microbiome in specific ways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Elstrott
Chief Executive Officer
Dale Pfost
Chief Scientific Officer
Mark Heiman
Browse more venture capital transactions:
Prev: 11/3/2017: Vital Proteins venture capital transaction
Next: 11/3/2017: PayQwick venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs